Annette Tumolo - Nov 11, 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Executive Vice President
Signature
/s/ Annette Tumolo
Stock symbol
BIO
Transactions as of
Nov 11, 2021
Transactions value $
-$2,959,154
Form type
4
Date filed
11/15/2021, 09:55 AM
Previous filing
Sep 9, 2021
Next filing
Jul 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $204K +613 +13.35% $333.34 5.21K Nov 11, 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $167K +500 +9.6% $333.34 5.71K Nov 11, 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $227K +433 +7.59% $524.30 6.14K Nov 11, 2021 Direct
transaction BIO Bio-Rad A Common Stock Sale -$324K -433 -7.05% $748.08 5.71K Nov 11, 2021 Direct
transaction BIO Bio-Rad A Common Stock Sale -$459K -613 -10.74% $748.84 5.09K Nov 11, 2021 Direct
transaction BIO Bio-Rad A Common Stock Sale -$375K -500 -9.82% $750.00 4.59K Nov 11, 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $95.6K +600 +13.06% $159.32 5.19K Nov 12, 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $518K +2.4K +46.21% $215.98 7.59K Nov 12, 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $587K +1.8K +23.7% $326.15 9.39K Nov 12, 2021 Direct
transaction BIO Bio-Rad A Common Stock Sale -$3.6M -4.8K -51.1% $750.05 4.59K Nov 12, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -433 -24.99% $0.00 1.3K Nov 11, 2021 Bio-Rad A Common Stock 433 $524.30 Direct F2
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.11K -39.98% $0.00 1.67K Nov 11, 2021 Bio-Rad A Common Stock 1.11K $333.34 Direct F3
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.8K -60% $0.00 1.2K Nov 12, 2021 Bio-Rad A Common Stock 1.8K $326.15 Direct F4
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.4K -80% $0.00 600 Nov 12, 2021 Bio-Rad A Common Stock 2.4K $215.98 Direct F5
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -600 -100% $0.00* 0 Nov 12, 2021 Bio-Rad A Common Stock 600 $159.32 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $750.00 to $750.61, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The option, representing a right to purchase a total of 1,733 shares, became exercisable in four equal annual installments beginning on September 2, 2021, which was the first anniversary of the date on which the option was granted.
F3 The option, representing a right to purchase a total of 2,784 shares, became exercisable in five equal annual installments beginning on September 3, 2020, which was the first anniversary of the date on which the option was granted.
F4 The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 4, 2019, which was the first anniversary of the date on which the option was granted.
F5 The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted.
F6 The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.